Read more Read more Read more Read more Read more Read more
Chan Zuckerberg Initiative fund research on neurodegenerative diseases
https://www.chanzuckerberg.com/science/projects-challenge-network
World Alzheimer’s Day
Why diagnosing Alzheimer’s today is so difficult—and how we can do better (By Bill Gates)
Development of a lab-on-a-chip method for rapid assay of Xylella fastidiosa
High performance plasma amyloid-β biomarkers for Alzheimer’s disease
Pharma giant ending Alzheimer's research
Scientists uncover the structure of tau filaments from Alzheimer's disease
A scientific team from IMEC received funding from Chan Zuckerberg Initiative (CZI) to work on Neurodegenerative Diseases. The team plans to create a new chip to study the mechanisms of Parkinson’s disease.
September 21st every year is World Alzheimer’s Day around the world. This is an international campaign aimed at raising awareness and challenge the common stigma that surrounds Alzheimer related dementia. Alzheimer’s is a progressive disease that impairs memory and other mental functions.
It is the most common form of dementia that generalizes memory loss and loss of other essential cognitive abilities that are serious enough to interfere with an individual’s daily life.
This article originally appeared on www.gatesnotes.com
Researchers at CNR Nanotec, MADIA project partner, pubished an interesting study on Development of a lab-on-a-chip method for rapid assay of Xylella fastidiosa.
"The US-based pharmaceutical giant said it would be ending its neuroscience discovery programmes following a review, and 300 jobs would be lost.
The Alzheimer's Society called the news "disappointing" and a "heavy blow" to those living with dementia. "
Researchers at the MRC Laboratory of Molecular Biology (LMB) have, for the first time, revealed the atomic structures of one of the two types of the abnormal filaments which lead to Alzheimer's disease.